Comparison of Technical and Clinical Outcome of Transjugular Portosystemic Shunt Placement Between a Bare Metal Stent and a PTFE-Stentgraft Device von Lauermann, J., Potthoff, A., Mc Cavert, M., Marquardt, S., Vaske, B., Rosenthal, H., von Hahn, T., Wacker, F., Meyer, B. C., Rodt, Thomas

Volltext

Erratum to: Comparison of Technical and Clinical Outcome of Transjugular Portosystemic Shunt Placement Between a Bare Metal Stent and a PTFE-Stentgraft Device von Lauermann, J., Potthoff, A., Mc Cavert, M., Marquardt, S., Vaske, B., Rosenthal, H., von Hahn, T., Wacker, F., Meyer, B. C., Rodt, Thomas

Volltext

Efficacy and safety of sofosbuvir/ledipasvir for the treatment of patients with hepatitis C virus re-infection after liver transplantation von Ciesek, S., Proske, V., Otto, B., Pischke, S., Costa, R., Lüthgehetmann, M., Polywka, S., Klempnauer, J., Nashan, B., Manns, M.P., von Hahn, T., Lohse, A.W., Wedemeyer, H., Mix, H., Sterneck, M.

Volltext

A novel mid-scale screening assay to identify compounds with anti-HDV activity von Buchmann, B, Döhner, K, Schirdewahn, T, Sodeik, B, Manns, M, Wedemeyer, H, Ciesek, S, Von Hahn, T

Volltext

Hepatitis C virus core antigen testing in liver and kidney transplant recipients von Heidrich, B., Pischke, S., Helfritz, F. A., Mederacke, I., Kirschner, J., Schneider, J., Raupach, R., Jäckel, E., Barg-Hock, H., Lehner, F., Klempnauer, J., von Hahn, T., Cornberg, M., Manns, M. P., Ciesek, S., Wedemeyer, H.

Volltext

Very low rates of Helicobacter pylori infection in organ transplant recipients presenting with peptic ulcer disease von Thiele, T, Manns, M P, Lankisch, T O, von Hahn, T

Volltext

High SVR 12 rates following treatment with direct acting antiviral agents (DAA) in a German multicentre cohort of HCV/HIV-1 coinfected patients on the transplant waiting list with... von Schwarz, J, Werner, C, Steurer, M, Spengler, U, Wedemeyer, H, von Hahn, T, Stremmel, W, Pathil-Warth, A, Berg, T, Engelmann, C, Seybold, U, Schott, E, Blessin, U, Malek, N, Lauer, U, Berg, C

Volltext

Retreatment of Patients who Failed Daa-Combination Therapies: Real-World Experience from a Large Hepatitis C Resistance Database von Vermehren, J, Susser, S, Dietz, J, von Hahn, T, Petersen, J, Hinrichsen, H, Spengler, U, Mauss, S, Berg, C, Zeuzem, S, Sarrazin, C

Volltext

Impact of Genetic Polymorphisms in the SCARB1 Gene on Hepatitis C Virus von Westhaus, S, Deest, M, Stanke, F, Heckl, D, Schambach, A, Manns, M.P, Berg, T, Sarrazin, C, Ciesek, S, von Hahn, T

Volltext

Heteromeric KCNE2/KCNQ1 potassium channels in the luminal membrane of gastric parietal cells von Heitzmann, Dirk, Grahammer, Florian, von Hahn, Thomas, Schmitt‐Gräff, Annette, Romeo, Elisa, Nitschke, Roland, Gerlach, Uwe, Lang, Hans Jochen, Verrey, François, Barhanin, Jacques, Warth, Richard

Volltext

1147 EFFECT OF GENETIC POLYMORPHISMS IN THE CD81 GENE ON HEPATITIS C VIRUS CELL ENTRY AND NEUTRALIZATION WITH ANTI-CD81 ANTIBODIES von Deest, M, Steinmann, E, Manns, M.P, von Hahn, T, Ciesek, S

Volltext

O53 SERUM LEVELS OF THE ENDOGENOUS HCV ENTRY INHIBITOR OXIDIZED LDL (OXLDL) PREDICT SVR FOLLOWING INTERFERON-BASED THERAPY OF CHRONIC HEPATITIS C von Westhaus, S, Solbach, P, Deest, M, Berg, T, Manns, M.P, Ciesek, S, Sarrazin, C, von Hahn, T

Volltext

P211 HOST mTORC1 SIGNALING IS REQUIRED FOR HEPATITIS C VIRUS (HCV) RNA REPLICATION von Stöhr, S, Sandmann, L, Pfänder, S, Dazert, E, Manns, M.P, Steinmann, E, von Hahn, T, Ciesek, S

Volltext

Hepatitis C Virus Screening Project of Patients on Current Anti-HCV Therapy von Knops, E, Kalaghatgi, P, Neumann-Fraune, M, Heger, E, Schuelter, E, Lengauer, T, Keitel, V, Goeser, T, Schuebel, N, von Hahn, T, Peuser, I, Qurishi, N, Römer, K, Scholten, S, Daeumer, M, zur Wiesch, J.S, Baumgarten, A, Obermeier, M, Walter, H, Kaiser, R, Sierra, S

Volltext

877 OXIDIZED LOW DENSITY LIPOPROTEIN (OXLDL) IS A PAN-GENOTYPE INHIBITOR OF HCV ENTRY THAT ACTS IN A SR-BI DEPENDENT MANNER von Westhaus, S, Ciesek, S, Bankwitz, D, Agne, C, Luchtefeld, M, Schieffer, B, Manns, M.P, Pietschmann, T, von Hahn, T

Volltext

872 IMPACT OF ANTI-RETROVIRAL AGENTS ON SUSCEPTIBILITY TO AND REPLICATION OF HEPATITIS C VIRUS IN VITRO von Sandmann, L, Back, D, Wedemeyer, H, Manns, M.P, Pietschmann, T, von Hahn, T, Ciesek, S

Volltext

772 SINGLE NUCLEOTIDE POLYMORPHISMS IN HUMAN CYCLOPHILIN A AND THEIR INFLUENCE ON HCVRNA REPLICATION IN VITRO von von Hahn, T, Karavul, B, Steinmann, E, Potthoff, A, Strassburg, C.P, Wedemeyer, H, Manns, M.P, Pietschmann, T, Ciesek, S

Volltext

1020 EPIDEMIOLOGICAL TRENDS IN INCIDENCE AND MORTALITY OF HEPATOBILIARY CANCERS IN GERMANY von Von Hahn, T, Ciesek, S, Wegener, G, Weissmueller, T, Manns, M.R, Greten, T.F, Malek, N

Volltext

Genetic variation in CLDN1 and susceptibility to hepatitis C virus infection von Bekker, V., Chanock, S. J., Yeager, M., Hutchinson, A. A., Von Hahn, T., Chen, S., Xiao, N., Dotrang, M., Brown, M., Busch, M. P., Edlin, B. R., Rice, C. M., O'Brien, T. R.

Volltext

Chronic hepatitis delta virus infection leads to functional impairment and severe loss of MAIT cells von Dias, Joana, Hengst, Julia, Parrot, Tiphaine, Leeansyah, Edwin, Lunemann, Sebastian, Malone, David F.G., Hardtke, Svenja, Strauss, Otto, Zimmer, Christine L., Berglin, Lena, Schirdewahn, Thomas, Ciesek, Sandra, Marquardt, Nicole, von Hahn, Thomas, Manns, Michael P., Cornberg, Markus, Ljunggren, Hans-Gustaf, Wedemeyer, Heiner, Sandberg, Johan K., Björkström, Niklas K.

Volltext